We are talking about medicines with semaglutide, a substance used in Ozempika. At the same time, Russians are buying analogues of the drug not for the treatment of diabetes, but for weight loss, the media noted.
Photo: ru.freepik.com
The total cost of medicines with semaglutide sold in Russia this year amounted to 4.9 billion rubles. The figures for the same period in 2023 were noticeably lower — 206.8 thousand packages worth 2.1 billion rubles.
Recall that on the eve it was reported that in Russia in 2025, another analogue of a weight loss drug from the United States will appear. It will be called "Sejaro".
